Summary of Research: Efficacy and Safety of Delgocitinib Cream in Adults with Moderate to Severe Chronic Hand Eczema (DELTA 1 and DELTA 2): Results from Multicentre, Randomised, Controlled, Double-Blind, Phase 3 Trials
Authors: Bissonnette R, Albreiki F, Ehst BD, Al Hammadi A, Schliemann S, Yang B, Zhang J, BunickCG. Read more on pubmed
Dupilumab Treatment Up to 5 Years Shows No Clinically Meaningful Changes in Laboratory Parameters in Adults with Moderate-to-Severe Atopic Dermatitis
Authors: Simpson EL, Bissonnette R, Deleuran M, Nakahara T, Galus R, de Bruin-Weller M, Coleman A, van Spall M, Chen Z, Avetisova E, Bastian M, Khokhar FA. Read more on pubmed
Episode 38: Raelle Kennedy (Woke Within Skin) – Eczema, Equity, and Empowerment
Our guest is Raelle Kennedy Brown, a brand marketing consultant, video producer, writer, patient advocate, and founder of Woke Within Skin, a platform dedicated to empowering individuals living with chronic conditions through storytelling, education, and community connection. Through Woke Within, Raelle blends advocacy, lived experience, and communication strategy to help organizations better understand the […]
Icotrokinra induces early and sustained pharmacodynamic responses in phase IIb study of patients with moderate-to-severe psoriasis
Authors: David Strawn, James G Krueger, Robert Bissonnette, Kilian Eyerich, Laura K Ferris, Amy S Paller, Andreas Pinter, Dylan Richards, Elizabeth Y Chen, Kate Paget, Daniel Horowitz, Roohid Parast, Joshua J Rusbuldt, Jocelyn Sendecki, Sunita Bhagat, Lynn P Tomsho, Ching-Heng Chou, Marta E Polak, Brice E Keyes, Emily Bozenhardt, Yuan Xiong, Wangda Zhou, Cynthia DeKlotz, […]
Rapid Transcriptomics Brings Actionable Data to Early-Phase Topical Trials
In this article published by Today’s Clinical Lab, StĂ©phanie LĂ©garĂ©, Scientific Advisor at Indero, shares about early transcriptomic readouts reveal pharmacodynamic activity in skin within daysâa shift toward earlier molecular decision-making. Read More
Episode 37: Simon Grant (Ascilion) & ThĂ©o Boyer – ISF: A New Dimension in Skin Biomarkers
Resources: [email protected]: Use this email to let us know what you want to hear about. https://www.ascilion.com/ This episode explores the future of skin biomarkers. Featuring insights from Simon Grant, CEO of Ascilion, and ThĂ©o Boyer, Senior Project Coordinator at Indero, the episode examines how dermal interstitial fluid (d-ISF) could revolutionize dermatology. Our guests illuminate […]
Top Dermatology Conferences to Attend
The dermatology clinical research industry thrives on innovation, collaboration, and scientific advancements. Conferences are essential in nurturing these aspects, offering platforms for experts to exchange knowledge, discuss breakthroughs, and join forces to achieve the ultimate common goal: discovering new therapies and improving patientsâ lives. Here, we highlight the top dermatology conferences that make significant contributions […]
Targeted Oral Peptide Icotrokinra for Psoriasis Involving High-Impact Sites
Authors: Gooderham M, Lain E, Bissonnette R, Huang YH, Lynde CW, Hoffmann M, Song EJ, Weirich O, Ceitlin RHG, Rubens JH, Delozier AM, Ota T, Hsu M-C, Li S, DeKlotz CMC, Nunes F, Warren RB Read more on pubmed
Efficacy and safety of rocatinlimab for the treatment of moderate-to-severe atopic dermatitis in ROCKET-IGNITE and ROCKET-HORIZON: two global, double-blind, placebo-controlled, randomised phase 3 clinical trials
Authors: Guttman-Yassky E, Kabashima K, Worm M, Luna PC, Hong CHH, Chovatiya R, Berstein JA, Kern JS, Ehst BD, Magnolo N, Herranz-Pinto P, Stein Gold L, Sofen H, Pink AE, Esfandiari E, Arai T, Shi R, Barragan C, Kricorian G, Schwartz-Sagi L, Bissonnette R Read more on pubmed
Interview with Dr. Robert Bissonnette: Indero Introduces New Early Phase 1 Model for Topical NCEs, Shortening Study Duration from 8-12 Weeks to â€3 Days
In this exclusive interview, Dr. Robert Bissonnette shares insights from Inderoâs internally-led study, which introduces a novel approach to early phase topical drug evaluation. By leveraging quantitative gene expression analysis and non-invasive tape strip sampling, this method promises to transform the assessment of new chemical entities (NCEs), offering rapid, cost-effective, and patient-friendly solutions for […]
